[Skip to Content]
[Skip to Content Landing]
Views 301
Citations 0
Comment & Response
October 2, 2013

Mortality Reporting and Pay-for-Performance Programs—Reply

Author Affiliations
  • 1Department of Cardiology, Methodist Medical Center, Peoria, Illinois
 

Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2013;310(13):1405. doi:10.1001/jama.2013.277987

In Reply I agree with Dr Bourque and colleagues that current methods of risk adjustment are imperfect and that prolonging life-sustaining measures in patients with little or no likelihood of recovery can be harmful. In contrast, I disagree that the inclusion of 30-day mortality data in hospital value–based purchasing will result in underuse of hospice services. A recent survey of Medicare beneficiaries indicates an increase in hospice use at the time of death.1 Regardless of the specific effect, I am in agreement with Bourque et al that incentivizing specific outcomes has the potential to influence physician behavior and health care delivery.

×